Tesla’s Losing Battle For EV Market Share In Europe Highlights Its Sales Growth Challenge

Summary:

  • Tesla’s Q4 results indicate that its era of fast sales growth is over.  An analysis of the European market explains why sales growth is slowing and where things are likely headed.
  • Tesla’s emerging problem in Europe is arguably its decision to manufacture in Germany, which is an increasingly expensive place to do business, while its German & Asian competitors are flocking to Hungary.
  • Tesla is likely to continue losing EV market share in Europe, as its competitors are positioning themselves to produce EVs at a lower cost.
  • I expect its shares to be range-bound between $100/share and $300/share for the foreseeable future, therefore, $150/share or below should be considered a good entry point.

Tesla Shanghai Gigafactory

Xiaolu Chu

Investment thesis: Having established itself as a dominant, profitable EV producer, Tesla (NASDAQ:TSLA) recently moved on to the next phase in its competition with emerging EV producers, namely an increasingly brutal fight for market share. With the


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *